Suc-[Glu9, Ala11,15]-Endothelin-1 (8 – 21)

Suc-[Glu9, Ala11,15]-Endothelin-1 (8 – 21)

0.5 mg
€105,00

Sie können eine Angebotsanfrage erstellen, nachdem Sie das Produkt in den Warenkorb gelegt haben.

Zu Produktinformationen springen
Suc-[Glu9, Ala11,15]-Endothelin-1 (8 – 21)
  • Suc-[Glu9, Ala11,15]-Endothelin-1 (8 – 21)
  • Suc-[Glu9, Ala11,15]-Endothelin-1 (8 – 21)

Suc-[Glu9, Ala11,15]-Endothelin-1 (8 – 21)

Produkt-ID: 4285

Suc – Asp – Glu – Glu – Ala – Val – Tyr – Phe – Ala – His – Leu – Asp – Ile – Ile – Trp Suc: Succinyl

€105,00
exkl. 19% MwSt.
Beschreibung

IRL 1620

M.W. 1820.9

C86H117N17O27

142569-99-1

Suc – Asp – Glu – Glu – Ala – Val – Tyr – Phe – Ala – His – Leu – Asp – Ile – Ile – Trp Suc: Succinyl

ETB Receptor Selective AgonistThe biological activity of this peptide is examined by the Division of Pharmacology, Peptide Institute, Inc.

Synthetic Product

The purity is guaranteed to be higher than 99% by HPLC

Referenzen:

1. M. Takai, I. Umemura, K. Yamasaki, T. Watakabe, Y. Fujitani, K. Oda, Y. Urade, T. Inui, T. Yamamura and T. Okada, Biochem. Biophys. Res. Commun., 184, 953 (1992) (Original) 2. S.S. Shetty, T. Okada, R.L. Webb, D. DelGrande and R.W. Lappe, Biochem. Biophys. Res. Commun., 191, 459 (1993) (Pharmacol.) 3. W.G. Haynes, A.P. Davenport and D.J. Webb, Trends Pharmacol. Sci., 14, 225 (1993) (Report; 3rd Int. Conf. Endothelin.) 4. A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993) (Review)

This peptide is distributed under the technical and scientific advices of International Research Laboratories of Novartis Pharma K.K.

You may also like